基因载体市场：按载体类型、有效载荷类型、应用、疾病领域、递送途径、递送方式、最终用户和地区划分

基因载体市场预计在 2025 年达到 93.5 亿美元，预计到 2032 年将达到 215.9 亿美元，2025 年至 2032 年的复合年增长率为 12.7%。

全球基因载体市场是生物技术和製药行业的重要组成部分，涵盖了旨在将治疗性遗传物质输送到目标细胞以治疗各种疾病的先进递送系统。基因载体作为载体，将包括DNA、RNA和其他核酸在内的遗传物质导入患者细胞，使其能够纠正遗传缺陷、增强免疫反应或递送治疗性蛋白质。

该市场涵盖多种载体类型，包括病毒载体（腺病毒、慢病毒、逆转录病毒、腺结合病毒）、非病毒载体（脂质体转染、电穿孔、显微注射）以及新兴的混合系统。遗传性疾病、癌症和罕见疾病的日益普遍显着增加了对创新基因治疗解决方案的需求，使基因载体成为个人化医疗方法中的关键组成部分。

由于基因治疗研究投入的增加、基因治疗监管核准的推进以及载体工程技术的进步，市场正经历显着增长。领先的製药公司、生技公司和研究机构正积极致力于开发新型载体系统，以提高递送效率、降低免疫抗原性并增强治疗效果，从而扩大肿瘤学、眼科学、免疫学和罕见疾病治疗领域的市场潜力。

市场动态

全球基因载体市场受多种主要因素驱动，其中包括遗传性疾病和癌症发病率的不断上升，这迫切需要创新疗法，而基因载体恰好能够提供这种疗法。对基因治疗研发的大量投资，以及政府资金和创业投资的不断增加，都在推动市场成长。

基因治疗临床试验数量的增加以及近期监管部门的核准，包括美国FDA核准的多种基因治疗产品，为市场创造了有利条件。载体工程技术的进步，例如靶向特异性的提高和免疫抗原性的降低，正在提升治疗效果和患者安全性。然而，市场也面临许多限制因素，主要在于基因载体的研发和生产高成本，这限制了其普及性和商业性可行性。

复杂的监管要求和漫长的核准流程阻碍了市场准入和产品商业化。病毒载体诱导的免疫反应、潜在的插入突变以及长期影响等安全隐患仍然是市场接受度的障碍。此外，载体设计方面的技术挑战，例如有效载荷能力有限和组织特异性标靶化困难，也限制了其治疗应用。然而，市场格局仍蕴藏着巨大的机会。

基因载体在治疗治疗选择有限的罕见疾病领域的应用日益广泛，展现出盈利的成长潜力。亚太和拉丁美洲等新兴市场医疗基础设施的改善和公众意识的提高，正在释放这些地区尚未开发的潜力。製药公司和生物技术公司之间的伙伴关係正在推动创新和市场扩张。新一代载体的研发，凭藉其更高的安全性、更强的递送能力以及有望降低生产成本的生产技术进步，为市场参与企业带来了显着的成长机会。

本次调查的主要特点

• 本报告对全球基因载体市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
• 该报告重点介绍了各个细分市场的潜在商机，并为该市场说明了一个有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 该报告根据以下参数对全球基因载体市场的主要企业进行了分析：公司概况、产品系列、主要特征、财务绩效和策略。
• 本报告的研究结果将使负责人和企业经营团队能够就即将推出的产品、类型升级、市场扩张和行销策略做出明智的决策。
• 这份全球基因载体市场报告针对该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过各种用于分析全球基因载体市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 法规环境
• 产品上市及核准
• PEST分析
• 波特分析
• 併购趋势
• 产业趋势

4. 2020-2032年全球基因载体市场（依载体类型划分）

• 病毒载体
• 非病毒载体

5. 2020-2032年全球基因载体市场（依酬载类型划分）

• DNA载体
• RNA载体
• siRNA/shRNA载体
• CRISPR/Cas 组件
• 反义寡核苷酸
• mRNA载体

6. 2020-2032年全球基因载体市场（依应用领域划分）

• 基因替代疗法
• 基因添加/增强疗法
• 基因静默/敲除
• 基因编辑（CRISPR、ZFN、TALEN）
• 细胞疗法生产（CAR-T、改良型NK/T细胞）
• 疫苗（预防性和治疗性）
• 仅供研究使用（临床前体外/体内工具）

7. 2020-2032年全球基因载体市场（依治疗领域划分）

• 肿瘤学
• 神经病学
• 循环系统/代谢性疾病
• 眼科
• 血液学/免疫学
• 感染疾病
• 肌肉骨骼与遗传性肌肉疾病
• 皮肤科和伤口创伤治疗
• 其他罕见遗传疾病

8. 2020-2032年全球基因载体市场（依递送途径划分）

• 静脉注射
• 肌肉内注射
• 皮下
• 鞘内注射
• 瘤内给药
• 眼
• 吸入
• 其他的

9. 2020-2032年全球基因载体市场（以递送方式划分）

• 体内递送
• 体外分娩

10. 2020-2032年全球基因载体市场（依最终用户划分）

• 生物製药和生物技术公司
• CDMO/CMO（合约开发与生产组织）
• 学术和研究机构
• 政府和非营利研究机构
• 院内及专门的基因治疗中心

11. 2020-2032年全球基因载体市场（按地区划分）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十二章 竞争格局

• Lonza Group
• Thermo Fisher Scientific
• Catalent Inc
• Oxford Biomedica
• FUJIFILM Diosynth Biotechnologies
• Advanced Therapies, LLC.
• Aldevron
• AGC Biologics
• SIRION Biotech
• FinVector
• Merck KGaA
• uniQure
• Charles River Laboratories
• Takara Bio

第十三章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十四章 参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Gene Vector Market is estimated to be valued at USD 9.35 Bn in 2025 and is expected to reach USD 21.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

The global gene vector market represents a pivotal segment within the biotechnology and pharmaceutical industries, encompassing sophisticated delivery systems designed to transport therapeutic genetic material into target cells for treatment of various diseases. Gene vectors serve as vehicles that facilitate the introduction of genetic material, including DNA, RNA, and other nucleic acids, into patient cells to correct genetic defects, enhance immune responses, or provide therapeutic proteins.

This market encompasses various vector types including viral vectors (adenovirus, lentivirus, retrovirus, adeno-associated virus), non-viral vectors (lipofection, electroporation, microinjection), and emerging hybrid systems. The growing prevalence of genetic disorders, cancer, and rare diseases has significantly amplified the demand for innovative gene therapy solutions, positioning gene vectors as critical components in personalized medicine approaches.

The market has witnessed substantial growth driven by increasing investments in gene therapy research, regulatory approvals for gene-based treatments, and technological advancements in vector engineering. Major pharmaceutical companies, biotechnology firms, and research institutions are actively developing novel vector systems to improve delivery efficiency, reduce immunogenicity, and enhance therapeutic outcomes, thereby expanding the market's potential across oncology, ophthalmology, immunology, and rare disease applications.

Market Dynamics

The global gene vector market is propelled by several key drivers, including the rising incidence of genetic disorders and cancer worldwide, which necessitates innovative therapeutic approaches that gene vectors can provide. Substantial investments in gene therapy research and development, coupled with increasing government funding and venture capital investments, are accelerating market growth.

The growing number of clinical trials for gene therapies and recent regulatory approvals, such as U.S. FDA approvals for various gene therapy products, have created favorable market conditions. Technological advancements in vector engineering, including improved targeting specificity and reduced immunogenicity, are enhancing therapeutic efficacy and patient safety profiles. However, the market faces significant restraints, primarily the high costs associated with gene vector development and manufacturing, which limit accessibility and commercial viability.

Complex regulatory requirements and lengthy approval processes create barriers for market entry and product commercialization. Safety concerns related to viral vector-induced immune responses, potential insertional mutagenesis, and long-term effects continue to challenge market acceptance. Additionally, technical challenges in vector design, including limited payload capacity and tissue-specific targeting difficulties, restrict therapeutic applications. Nevertheless, substantial opportunities exist within the market landscape.

The expanding applications of gene vectors in treating rare diseases, where limited therapeutic options exist, present lucrative growth prospects. Emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and increasing awareness. Collaborative partnerships between pharmaceutical companies and biotechnology firms are fostering innovation and market expansion. The development of next-generation vectors with improved safety profiles and enhanced delivery capabilities, along with advances in manufacturing technologies that could reduce production costs, represent significant growth opportunities for market participants.

Key Features of the Study

• This report provides in-depth analysis of the global gene vector market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gene vector market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent Inc, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Advanced Therapies, LLC., Aldevron, AGC Biologics, SIRION Biotech, FinVector, Merck KGaA, uniQure, Charles River Laboratories, Takara Bio.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gene vector market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene vector market

Market Segmentation

• Vector Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Viral Vectors
  • Adenoviral Vectors
  • Adeno-Associated Viral (AAV) Vectors
  • Lentiviral Vectors
  • Gamma-Retroviral Vectors
  • Herpes Simplex Viral (HSV) Vectors
  • Poxviral/Vaccinia Vectors
  • Other Viral Vectors (Sendai, VSV, Baculovirus, etc.)
  • Non-Viral Vectors
  • Plasmid DNA Vectors
  • Lipid-Based Nanoparticle (LNP) Vectors
  • Polymeric/Synthetic Nanoparticle Vectors
  • Inorganic Nanoparticle Vectors (gold, silica-based, etc.)
• Payload Type Insights (Revenue, USD Bn, 2020 - 2032)
  • DNA Vectors
  • RNA Vectors
  • siRNA/shRNA Vectors
  • CRISPR/Cas Components
  • Antisense Oligonucleotides
  • mRNA Vectors
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Gene Replacement Therapy
  • Gene Addition/Augmentation Therapy
  • Gene Silencing/Knockdown
  • Gene Editing (CRISPR, ZFN, TALEN)
  • Cell Therapy Manufacturing (CAR-T, engineered NK/T cells)
  • Vaccines (prophylactic and therapeutic)
  • Research Use Only (preclinical in vitro/in vivo tools)
• Disease Area Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Neurology
  • Cardiovascular and Metabolic
  • Ophthalmic
  • Hematologic and Immunologic
  • Infectious Diseases
  • Musculoskeletal and Genetic Muscle Disorders
  • Dermatology and Wound Healing
  • Other Rare Genetic Disorders
• Delivery Route Insights (Revenue, USD Bn, 2020 - 2032)
  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Intrathecal
  • Intratumoral
  • Ocular
  • Inhalation
  • Others
• Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
  • In Vivo Delivery
  • Ex Vivo Delivery
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Biopharmaceutical and Biotechnology Companies
  • CDMOs/CMOs (Contract Development and Manufacturing Organizations)
  • Academic and Research Institutes
  • Government and Non-Profit Research Organizations
  • Hospital-Based and Specialty Gene Therapy Centers
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Lonza Group
  • Thermo Fisher Scientific
  • Catalent Inc
  • Oxford Biomedica
  • FUJIFILM Diosynth Biotechnologies
  • Advanced Therapies, LLC.
  • Aldevron
  • AGC Biologics
  • SIRION Biotech
  • FinVector
  • Merck KGaA
  • uniQure
  • Charles River Laboratories
  • Takara Bio

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Gene Vector Market, By Vector Type
  • Global Gene Vector Market, By Payload Type
  • Global Gene Vector Market, By Application
  • Global Gene Vector Market, By Disease Area
  • Global Gene Vector Market, By Delivery Route
  • Global Gene Vector Market, By Delivery Mode
  • Global Gene Vector Market, By End User
  • Global Gene Vector Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Gene Vector Market, By Vector Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Viral Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Adenoviral Vectors
    • Adeno-Associated Viral (AAV) Vectors
    • Lentiviral Vectors
    • Gamma-Retroviral Vectors
    • Herpes Simplex Viral (HSV) Vectors
    • Poxviral/Vaccinia Vectors
    • Other Viral Vectors (Sendai, VSV, Baculovirus, etc.)
• Non-Viral Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Plasmid DNA Vectors
    • Lipid-Based Nanoparticle (LNP) Vectors
    • Polymeric/Synthetic Nanoparticle Vectors
    • Inorganic Nanoparticle Vectors (gold, silica-based, etc.)

5. Global Gene Vector Market, By Payload Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• DNA Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• RNA Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• siRNA/shRNA Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CRISPR/Cas Components
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antisense Oligonucleotides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• mRNA Vectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Vector Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Gene Replacement Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Addition/Augmentation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Silencing/Knockdown
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gene Editing (CRISPR, ZFN, TALEN)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Therapy Manufacturing (CAR-T, engineered NK/T cells)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vaccines (prophylactic and therapeutic)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Use Only (preclinical in vitro/in vivo tools)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Vector Market, By Disease Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular and Metabolic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ophthalmic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematologic and Immunologic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Musculoskeletal and Genetic Muscle Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatology and Wound Healing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Rare Genetic Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Vector Market, By Delivery Route, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Subcutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intrathecal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intratumoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ocular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inhalation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gene Vector Market, By Delivery Mode, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• In Vivo Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ex Vivo Delivery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Gene Vector Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• CDMOs/CMOs (Contract Development and Manufacturing Organizations)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Government and Non-Profit Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hospital-Based and Specialty Gene Therapy Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Gene Vector Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive Landscape

• Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Catalent Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Oxford Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FUJIFILM Diosynth Biotechnologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Therapies, LLC.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aldevron
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AGC Biologics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SIRION Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• FinVector
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• uniQure
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About us